Physician profile
Uma Saligram
NPI 1770800757
$14,089.89
in general payments reported to CMS, 2019-2025
58 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $1,482 · 2021: $3,003 · 2022: $2,995 · 2023: $3,558 · 2024: $2,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,789.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,185.67 | 2019-2023 | Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $1,175.55 | 2019-2024 | |
| Abbvie INC. | $1,117.50 | 2021-2024 | Botox, Ubrelvy, Qulipta |
| Teva Pharmaceuticals USA, INC. | $1,049.73 | 2019-2024 | Austedo Xr, Austedo, Ajovy |
| Biogen, INC. | $878.54 | 2019-2024 | Tysabri, Vumerity, Skyclarys |
| Sk Life Science, INC. | $799.43 | 2021-2024 | Xcopri |
| Lilly USA, LLC | $780.01 | 2019-2024 | Kisunla, Reyvow, Emgality |
| Allergan, INC. | $612.59 | 2019-2021 | |
| Pfizer INC. | $490.56 | 2021-2024 | |
| Eisai INC. | $435.80 | 2020-2024 | |
| Biohaven Pharmaceuticals, INC. | $401.11 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $399.57 | 2022-2024 | Ingrezza, Ongentys |
| Biohaven Pharmaceutical Holding Company LTD. | $346.95 | 2022 | |
| Amgen INC. | $302.12 | 2019-2024 | Uplizna |
| Boston Scientific Corporation | $290.34 | 2020-2024 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $260.24 | 2021-2023 | Uplizna |
| Genentech USA, INC. | $230.78 | 2023-2024 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Argenx US, INC. | $223.91 | 2023-2024 | Vyvgart Hytrulo, Vyvgart |
| Supernus Pharmaceuticals, INC. | $220.10 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $205.66 | 2019-2023 | Koselugo, Ultomiris |
| Sunovion Pharmaceuticals INC. | $194.53 | 2019-2021 | |
| Neurelis, INC. | $193.88 | 2020-2023 | Valtoco |
| Acorda Therapeutics, INC | $193.70 | 2020-2023 | Inbrija |
| Lundbeck LLC | $177.27 | 2020-2024 | Rexulti, Vyepti |
| Impel Pharmaceuticals INC. | $166.03 | 2022-2023 | Trudhesa |
| Avion Pharmaceuticals | $152.61 | 2022-2023 | Dhivy |
| Tanabe Pharma America, INC. | $146.43 | 2020-2024 | |
| Jazz Pharmaceuticals INC. | $121.66 | 2019-2024 | Xywav |
| Arbor Pharmaceuticals, INC. | $90.74 | 2019-2021 | |
| Genzyme Corporation | $90.21 | 2019-2024 | |
| Avanir Pharmaceuticals, INC. | $90.10 | 2020-2021 | |
| Kyowa Kirin, INC. | $89.43 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $81.05 | 2020-2021 | |
| Abbott Laboratories | $78.83 | 2021-2024 | Infinity |
| Acadia Pharmaceuticals INC | $71.93 | 2021-2022 | |
| Aprecia Pharmaceuticals, LLC | $71.70 | 2020 | |
| Ge Healthcare | $68.79 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $59.88 | 2023 | Nuedexta |
| Merz Pharmaceuticals, LLC | $54.76 | 2023-2024 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $53.86 | 2023 | Dysport |
| Biotronik Nro, INC. | $41.90 | 2023-2024 | Biotronik, Prospera |
| Siemens Medical Solutions USA, INC. | $38.75 | 2022 | |
| Octapharma USA, INC. | $37.73 | 2023 | Panzyga |
| Takeda Pharmaceuticals U.S.A., INC. | $35.46 | 2023 | Gammagard |
| Amneal Pharmaceuticals LLC | $34.72 | 2024 | Ongentys 50mg Capsules 30 |
| Grifols USA, LLC | $28.72 | 2019-2024 | Gamunex-C |
| Emd Serono, INC. | $27.06 | 2019 | |
| Medtronic, INC. | $26.37 | 2024 | Percept PC Brainsense |
| Sumitomo Pharma America, INC. | $24.86 | 2023-2024 | Aptiom |
| Alnylam Pharmaceuticals INC. | $22.32 | 2023 | Onpattro |
| Sanofi-Aventis U.S. LLC | $20.58 | 2020 | |
| Aquestive Therapeutics, INC. | $19.57 | 2021 | |
| Almatica Pharma LLC | $17.54 | 2021 | |
| Strongbridge US INC. | $17.16 | 2020 | |
| Celgene Corporation | $15.94 | 2023 | Zeposia |
| Azurity Pharmaceuticals, INC. | $14.37 | 2023 | Horizant |
| Nevro Corp. | $13.29 | 2023 | Senza |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Saligram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.